Huntington's disease

被引：72

作者：

Davies, S ^{[1
]}

Ramsden, DB ^{[1
]}

机构：

[1] Univ Birmingham, Dept Med, Div Med Sci, Birmingham B15 2TH, W Midlands, England

来源：

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2001年 / 54卷 / 06期

关键词：

Huntington's disease; neurodegenerative disorder; Huntingtin; NMDA receptors; kainate receptors;

D O I：

10.1136/mp.54.6.409

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

The most recent findings in the elucidation of the molecular pathology of Huntington's disease are reviewed. Particular interest has been paid to the role of huntingtin and its associated proteins in excitotoxicity mediated via NMDA and kainate receptors.

引用

页码：409 / 413

页数：5

共 61 条

[21] Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production [J].

Guidetti, P ;

Charles, V ;

Chen, EY ;

Reddy, PH ;

Kordower, JH ;

Whetsell, WO ;

Schwarcz, R ;

Tagle, DA .

EXPERIMENTAL NEUROLOGY, 2001, 169 (02) :340-350

[22] A POLYMORPHIC DNA MARKER GENETICALLY LINKED TO HUNTINGTONS-DISEASE [J].

GUSELLA, JF ;

WEXLER, NS ;

CONNEALLY, PM ;

NAYLOR, SL ;

ANDERSON, MA ;

TANZI, RE ;

WATKINS, PC ;

OTTINA, K ;

WALLACE, MR ;

SAKAGUCHI, AY ;

YOUNG, AB ;

SHOULSON, I ;

BONILLA, E ;

MARTIN, JB .

NATURE, 1983, 306 (5940) :234-238

[23] Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain [J].

Hackam, AS ;

Yassa, AS ;

Singaraja, R ;

Metzler, M ;

Gutekunst, CA ;

Gan, L ;

Warby, S ;

Wellington, CL ;

Vaillancourt, J ;

Chen, NS ;

Gervais, FG ;

Raymond, L ;

Nicholson, DW ;

Hayden, MR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41299-41308

[24]

Harris AS, 2001, J PSYCHIATR NEUROSCI, V26, P117

[25] Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles [J].

Hilditch-Maguire, P ;

Trettel, F ;

Passani, LA ;

Auerbach, A ;

Persichetti, F ;

MacDonald, ME .

HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2789-2797

[26] The molecular biology of Huntington's disease [J].

Ho, LW ;

Carmichael, J ;

Swartz, J ;

Wyttenbach, A ;

Rankin, J ;

Rubinsztein, DC .

PSYCHOLOGICAL MEDICINE, 2001, 31 (01) :3-14

[27] Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity [J].

Jana, NR ;

Tanaka, M ;

Wang, GH ;

Nukina, N .

HUMAN MOLECULAR GENETICS, 2000, 9 (13) :2009-2018

[28] Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release [J].

Jana, NR ;

Zemskov, EA ;

Wang, GH ;

Nukina, N .

HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1049-1059

[29] The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls [J].

Keckarevic, D ;

Culjkovic, B ;

Savic, D ;

Stojkovic, O ;

Kostic, V ;

Vukosavic, S ;

Romac, S .

JOURNAL OF NEUROGENETICS, 2000, 14 (04) :257-263

[30] Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? [J].

Kennedy, L ;

Shelbourne, PF .

HUMAN MOLECULAR GENETICS, 2000, 9 (17) :2539-2544

← 1 2 3 4 5 6 7 →